News Snapshot:
(Bloomberg) -- Wuxi Diagnostic Investment (Cayman) Ltd., a Shanghai-based integrated diagnostics service platform, is weighing an initial public offering in Hong Kong as soon as next year, people with knowledge of the matter said. .The Chinese firm is in discussions with potential advisers on a Hong Kong listing which could raise about $400 million, said the people, who asked not to be identified as the information is private. .Deliberations are at an early stage and details such as timing and fundraising size may change, the people said. Representatives for Wuxi Diagnostics didn’t immediately respond to a request for comment. .Backed...
